title: Transcatheter aortic valve replacement: When invasive surgery is not an option.
abstract: Aortic stenosis is a common problem that typically results from calcification and degenerative changes of the aortic valve that occur with advancing age. Because medical therapies have no clinically proven role, the management of severe aortic stenosis has primarily been surgical. For patients who are too high-risk for surgical aortic valve repair, transcatheter aortic valve repair (TAVR), approved by the FDA in 2011, may be an option. This article outlines what clinicians need to know about TAVR.
authors.affiliation: Matthew R. Dameron practices internal medicine in Roanoke, Va. Sulaiman Rathore practices at Carilion Clinic in Roanoke. The authors have disclosed no potential conflicts of interest, financial or otherwise.
authors.forename: Matthew R
authors.initials: MR
authors.lastname: Dameron
authors.forename: Sulaiman
authors.initials: S
authors.lastname: Rathore
mesh_terms: D001024:Aortic Valve Stenosis / Q000601:surgery*; D006801:Humans; D065467:Transcatheter Aortic Valve Replacement / Q000009:adverse effects